Theralizumab
Product Specifications
CAS Number
906068-56-2
Target
Others, Immunology/Inflammation related
Related Pathways
Others, Immunology/Inflammation
Purity
0.9946
Bioactivity
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ATGP2141-020 20 µg
Recombinant human DNA polymerase epsilon 3/POLE3 protein
Sign In for Pricing
View Details 
ARP70689_P050 100 µL
KIAA1751 Antibody - C-terminal region (ARP70689_P050)
Sign In for Pricing
View Details TL308499V 500 µL Each
UGT2A1 Human shRNA Lentiviral Particle (Locus ID 10941)
Sign In for Pricing
View Details MBS6443435-01 0.1 mL
WNK1 (With-No-Lysine Kinase 1, Kinase deficient protein, KDP, PSK, p65, HSN2, HSAN2, PRKWNK1) (PE)
Sign In for Pricing
View Details MBS6443435-02 5x 0.1 mL
WNK1 (With-No-Lysine Kinase 1, Kinase deficient protein, KDP, PSK, p65, HSN2, HSAN2, PRKWNK1) (PE)
Sign In for Pricing
View Details